Global Voice Restoration Devices Market - 2022-2029

Market Overview

The global voice restoration devices market was valued at US$ 531.29 million in 2021 and is estimated to reach US$ 602.75 million by 2029, growing at a CAGR of 9.58% during the forecast period (2022-2029).

Voice restoration devices are used with voice therapy, such as esophageal speech and stoma occlusion with the thumb, to help laryngectomy patients produce a statement. In most cases, the voice box is removed due to larynx cancer. The patient has to undergo specific voice restoration therapy involving devices and implants.

Market Dynamics

The increasing demand for these voice restoration devices, the rising incidence of larynx cancer, the increasing research and development expenditure and growth in novel product launches are expected to drive market growth.

The increasing novel product launches and demand for voice restoration devices will drive market growth.

The global market for voice restoration devices is primarily driven by the surge in demand for voice restoration devices in the healthcare industry, the rising number of product launches, and the many advantages of these electrolarynxes. Various studies are being conducted on novel minimally invasive ENT procedures that benefit voice restoration. For instance, in Oct 2021, InHealth Technology, a company that develops ENT products such as Blom-Singer voice restoration, announced the launch of the Blom-Singer Speak free HME hands-free valve. This product will be advantageous for patients who have undergone total laryngectomy.

Various latest technological advancements are taking place, and the number of voice restoration device launches is increasing, increasing the demand. The latest innovations in these devices are driving the growth of the market. For instance, Orbisana Healthcare's product Servox Digital XL electrolarynx is a voice prosthesis device that copies the activity of the voice box and amplifies the speech. It can be useful for individuals got tracheotomy procedures. Volume and frequency can be changed from settings.

High costs associated with voice restoration devices will hamper the market's growth.

However, the high cost of devices and procedures might hamper the market potential. Various types of voice prostheses and methods are available in the market. Many small and medium-sized clinics cannot order and prepay for a minimum stock of different brands and sizes of devices due to a lack of budget. The price of pneumatic artificial larynx devices ranges from approximately USD 75 to USD 150, while the neck-type electrolarynx device's price varies from USD 150 to USD 800.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. Market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Even though COVID-19 harms the industry, preparing and implementing backup plans as soon as possible for business operations is crucial. Various collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Jan 2022, ICU Medical acquired Smith's Medical, a medical device manufacturer.

Segment Analysis

The artificial larynx (Electrolarynx) segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The artificial larynx (Electrolarynx) segment is the highest market holder in the global voice restoration devices market. The artificial larynx (Electrolarynx) is the leading device type in the market, holding a dominant share. Electrolarynx is a vibrator that is externally operated and is placed on the chin or cheeks; that generates vibrations in the throat that are further converted into speech from the mouth of the patient. A significant advantage of the artificial larynx is that its use is often quickly and rapidly learned and is now available latest hand-free devices. The devices, specifical valves, are made of silicone in voice prosthesis and electronically operated devices in an electrolarynx. According to the NIH, in 2021, larynx cancer caused approximately 0.6% of deaths and 0.7% of new cases of all cancers globally. The novel development of innovative and advanced electrolarynx is increasing market growth. For instance, Romet Electronic Larynx introduced its Romet R700 Clarity programmable digital electronic larynx. It is a digital electrolarynx device that laryngectomy patients use. This digital device produces some mechanical vibrations having a low sound frequency of around 60-195 Hz. In the neck, these vibrations develop trembling in the oral cavity, which is the same as the human voice. Combining the starting and stopping sound vibrations with oral articulation generates human speech.

Geographical Analysis

North America holds the largest market share of the global voice restoration devices market.

North America dominates the global voice restoration devices market, primarily attributed to the increasing number of partnerships or collaborations between companies, the rising demand for voice restoration devices, and novel studies. Furthermore, factors including growing expenditure on research and development, the increasing incidence of laryngeal and hypopharyngeal cancer, and the adoption of voice restoration devices among patients will likely enhance the growth of the region's voice restoration devices market. The American Cancer Society estimated that about 12,470 new laryngeal cancer cases would be registered in the U.S. in 2022, out of which 3,820 people are expected to die from laryngeal cancer.

Moreover, the growing number of product launches is responsible for the market's growth. Other factors, such as the high spending of GDP on healthcare, stimulate the market's growth. Many key developments and technological advancements are taking place based in this region. For instance, in Sep 2021, Acclarent Inc, a subsidiary of Johnson & Johnson company of medical devices, developed minimally invasive ENT technologies and launched its AI-powered ENT technology. This technology simplifies surgical planning, and it provides real-time feedback during ENT navigation procedures.

Competitive Landscape

The voice restoration devices market is highly competitive with local and global companies. Atos Medical, Inhealth Technologies, Freudenberg Medical, Luminaud Inc., Romet Electronic Larynx, Smith's Medical (ICU Medical), Sanova Holding AG, Orbisana Healthcare, Acclarent Inc. (Johnson & Johnson), William Demant Holdings and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Oct 2022, Coloplast completed the acquisition of Atos Medical, an innovative medical device developer in laryngectomy and tracheostomy, after receiving the regulatory authority's approval. This will lead to the addition of new ENT and Respiratory care in Coloplast's business segment.

Atos Medical (Coloplast):

Overview:

Atos Medical is a company that designs and commercializes innovative medical devices in laryngectomy and tracheostomy. It was founded in 1986 and is headquartered in Malmo, Sweden. Atos provides its products in around 90 countries.

Product Portfolio:

Provox ActiValve: It is a prosthesis device specially developed for patients facing early leakage problems from voice prostheses. The valve flap and ring are fluoroplastic material that prevents candida destruction. While breathing and swallowing, the inadvertent opening of the valve flap will be prevented by the magnets.

The global voice restoration devices market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.